BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37906166)

  • 1. First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant.
    Bernaldo-de-Quirós E; Camino M; Martínez-Bonet M; Gil-Jaurena JM; Gil N; Hernández-Flórez D; Fernández-Santos ME; Butragueño L; Dijke IE; Levings MK; West LJ; Pion M; Correa-Rocha R
    J Exp Med; 2023 Dec; 220(12):. PubMed ID: 37906166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel GMP Protocol to Produce High-Quality Treg Cells From the Pediatric Thymic Tissue to Be Employed as Cellular Therapy.
    Bernaldo-de-Quirós E; Cózar B; López-Esteban R; Clemente M; Gil-Jaurena JM; Pardo C; Pita A; Pérez-Caballero R; Camino M; Gil N; Fernández-Santos ME; Suarez S; Pion M; Martínez-Bonet M; Correa-Rocha R
    Front Immunol; 2022; 13():893576. PubMed ID: 35651624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Generation of Cell Therapies Employing Regulatory T Cells (Treg) to Induce Immune Tolerance in Pediatric Transplantation.
    Bernaldo-de-Quirós E; Pion M; Martínez-Bonet M; Correa-Rocha R
    Front Pediatr; 2022; 10():862807. PubMed ID: 35633970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and expansion of thymus-derived regulatory T cells for use in pediatric heart transplant patients.
    Romano M; Sen M; Scottà C; Alhabbab RY; Rico-Armada A; Lechler RI; Burch M; Lombardi G
    Eur J Immunol; 2021 Aug; 51(8):2086-2092. PubMed ID: 33949684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of regulatory T cells on short-term graft outcome in kidney transplant recipients, a prospective observational, single-center study.
    Bejugama K; Taduri G; Guditi S
    Transpl Immunol; 2022 Aug; 73():101630. PubMed ID: 35643376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation.
    López-Abente J; Martínez-Bonet M; Bernaldo-de-Quirós E; Camino M; Gil N; Panadero E; Gil-Jaurena JM; Clemente M; Urschel S; West L; Pion M; Correa-Rocha R
    Sci Rep; 2021 Jan; 11(1):827. PubMed ID: 33436905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP-1 inhibitor-AG14361 suppresses acute allograft rejection via stabilizing CD4+FoxP3+ regulatory T cells.
    Gu W; Ge R; Zhu F; Li D; Liang R; Ge J; Wang Y; Li B; Qiu J
    Pathol Res Pract; 2020 Aug; 216(8):153021. PubMed ID: 32703489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients.
    Schaier M; Seissler N; Schmitt E; Meuer S; Hug F; Zeier M; Steinborn A
    PLoS One; 2012; 7(3):e34208. PubMed ID: 22470536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of circulating regulatory cluster of differentiation 4 T cells to endothelial progenitor cells predicts clinically significant acute rejection after heart transplantation.
    Choi DH; Chmura SA; Ramachandran V; Dionis-Petersen KY; Kobayashi Y; Nishi T; Luikart H; Dimbil S; Kobashigawa J; Khush K; Lewis DB; Fearon WF
    J Heart Lung Transplant; 2018 Apr; 37(4):496-502. PubMed ID: 29198869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance?
    Bei KF; Moshkelgosha S; Liu BJ; Juvet S
    Front Immunol; 2023; 14():1291649. PubMed ID: 38077395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.
    Fujimoto K; Uchida K; Yin E; Zhu J; Kojima Y; Uchiyama M; Yamamoto Y; Bashuda H; Matsumoto R; Tokushige K; Harada M; Inomata T; Kitaura J; Murakami A; Okumura K; Takeda K
    Transpl Immunol; 2021 Aug; 67():101405. PubMed ID: 33975012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression.
    Tsang JY; Tanriver Y; Jiang S; Leung E; Ratnasothy K; Lombardi G; Lechler R
    Transpl Immunol; 2009 Sep; 21(4):203-9. PubMed ID: 19446634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo Treg expansion under costimulation blockade targets early rejection and improves long-term outcome.
    Schwarz C; Mahr B; Muckenhuber M; Weijler AM; Unger LW; Pilat N; Latus M; Regele H; Wekerle T
    Am J Transplant; 2021 Nov; 21(11):3765-3774. PubMed ID: 34152692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model.
    Riella LV; Liu T; Yang J; Chock S; Shimizu T; Mfarrej B; Batal I; Xiao X; Sayegh MH; Chandraker A
    Am J Transplant; 2012 Apr; 12(4):846-55. PubMed ID: 22300534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft Protective and Intercellular Immunomodulatory Effects by Adoptive Transfer of an Agonistic Anti-BTLA mAb (3C10) Induced CD4
    Masaoka H; Yamamoto Y; Uchiyama M; Iguchi K; Nakamura M; Yagita H; Imazuru T; Shimokawa T
    Transplant Proc; 2024 Apr; 56(3):692-700. PubMed ID: 38360464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation.
    Chauhan SK; Saban DR; Lee HK; Dana R
    J Immunol; 2009 Jan; 182(1):148-53. PubMed ID: 19109145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.
    Brennan TV; Tang Q; Liu FC; Hoang V; Bi M; Bluestone JA; Kang SM
    J Surg Res; 2011 Jul; 169(1):e69-75. PubMed ID: 21571317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of miR-146a in regulatory T cells suppresses heart transplantation rejection in mice by increasing autophagy.
    Lu J; Liu Y; Wang W; Li P; Qi F
    Transpl Immunol; 2021 Apr; 65():101372. PubMed ID: 33581286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nox2-deficient Tregs improve heart transplant outcomes via their increased graft recruitment and enhanced potency.
    Trevelin SC; Zampetaki A; Sawyer G; Ivetic A; Brewer AC; Smyth LA; Marelli-Berg F; Köchl R; Lechler RI; Shah AM; Lombardi G
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.